Skip to main content Skip to navigation
Reducing opioid use via online pain management focus of $2.5M study
September 7, 2017

 By Addy Hatch, WSU Spokane

SPOKANE, Wash. – Marian Wilson, an assistant professor at the WSU College of Nursing, is joining a team of scientists who’ll lead a federally funded, $2.5 million study investigating whether an online pain management program can help patients with chronic pain reduce or eliminate the amount of prescription opioids they take.

Diabetes researcher receives early-career recognition
December 21, 2016

SPOKANE, Wash. – Anna Zamora-Kapoor has received an early/mid career grant of $50,000 for 12 months from the Robert Wood Johnson Foundation to study risk factors for type 2 diabetes in American Indians and Alaska Natives.

$10 million grant to study disease in native populations
August 26, 2016

By Doug Nadvornick, Elson S. Floyd College of Medicine

Buchwald-webSPOKANE, Wash. – A Washington State University researcher has received a $10 million grant to work with American Indian, Alaska Native, Native Hawaiian and Pacific Islander communities to reduce health risks related to high blood pressure.

Ask Dr. Universe: Why do we feel pain?
August 16, 2016

Dr-Universe-230PULLMAN, Wash. – Pain is unpleasant, but we need it for survival. Just the other day I was out exploring when I stubbed my paw and let out a big meow. My nervous system was doing its job.

Illuminating sulfides’ roles in the body
August 8, 2016

By Will Ferguson, College of Arts & Sciences

Ming-Xian-webPULLMAN, Wash. – For the first time, researchers at Washington State University have created an injectable compound or “probe” that illuminates hydrogen sulfide and hydrogen polysulfides in different colors when they are present in cells.

Scientist develops gene therapy for muscle wasting
July 26, 2016

By Seth Truscott, College of Agricultural, Human & Natural Resource Sciences

Dan-RodgersPULLMAN, Wash. – A discovery by Washington State University scientist Dan Rodgers and collaborator Paul Gregorevic could save millions of people suffering from muscle wasting disease.

Nasal spray may ease Parkinson’s, other disease symptoms
June 16, 2016

By Lori Maricle, College of Pharmacy

Jeannie-PadowskiSPOKANE, Wash. – Researchers have reported a 240 percent increase in the brain of the antioxidant glutathione after it is administered via nasal spray. Glutathione deficiency has been documented in a variety of central nervous system disorders, including Parkinson’s disease, multiple sclerosis, autism, Alzheimer’s disease, schizophrenia and bipolar disease.

Nursing student receives library research award
May 25, 2016

By Brenda Alling, WSU Vancouver

Sarah-HolmanVANCOUVER, Wash. – Of all infectious diseases that endanger young children’s lives, pneumonia remains the world’s biggest threat. Yet some simple, low-cost measures could go a long way toward reducing the problem.